000 | 01690 a2200457 4500 | ||
---|---|---|---|
005 | 20250510214817.0 | ||
264 | 0 | _c19770103 | |
008 | 197701s 0 0 eng d | ||
022 | _a0022-2623 | ||
024 | 7 |
_a10.1021/jm00231a012 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aCarr, A A | |
245 | 0 | 0 |
_aBis-basic-substituted polycyclic aromatic compounds. A new class of antiviral agents. 7. Bisalkamine esters of 9-oxoxanthene-2,7-dicarboxylic acid, 3,6-bis-basic ethers of xanthen-9-one, and 2,7-bis(aminoacyl)xanthen-9-ones-xanthenes, and -thioxanthenes. _h[electronic resource] |
260 |
_bJournal of medicinal chemistry _cSep 1976 |
||
300 |
_a1142-8 p. _bdigital |
||
500 | _aPublication Type: Comparative Study; Journal Article | ||
650 | 0 | 4 | _aAdministration, Oral |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAntiviral Agents _xchemical synthesis |
650 | 0 | 4 |
_aEncephalitis _xprevention & control |
650 | 0 | 4 | _aEncephalomyocarditis virus |
650 | 0 | 4 |
_aEnterovirus Infections _xprevention & control |
650 | 0 | 4 | _aInjections, Subcutaneous |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMice |
650 | 0 | 4 | _aSemliki forest virus |
650 | 0 | 4 | _aStructure-Activity Relationship |
650 | 0 | 4 | _aTime Factors |
650 | 0 | 4 |
_aVaccinia _xprevention & control |
650 | 0 | 4 |
_aXanthenes _xadministration & dosage |
700 | 1 | _aGrunwell, J F | |
700 | 1 | _aSill, A D | |
700 | 1 | _aMeyer, D R | |
700 | 1 | _aSweet, F W | |
700 | 1 | _aScheve, B J | |
700 | 1 | _aGrisar, J M | |
700 | 1 | _aFleming, R W | |
700 | 1 | _aMayer, G D | |
773 | 0 |
_tJournal of medicinal chemistry _gvol. 19 _gno. 9 _gp. 1142-8 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1021/jm00231a012 _zAvailable from publisher's website |
999 |
_c181636 _d181636 |